In 2023, the global sugar-based excipients market is expected to hit US$ 1068.41 million, expanding at a CAGR of 4.8%. By 2033, the market was estimated at US$ 1707.46 million. The growth of this market is mainly due to the increased use of combination-processed excipients.
Increasing utilization of co-processed excipients, patent cliffs for sugar excipients, and advancements in orally disintegrating tablets (ODTS) are factors driving sugar-based excipients market growth. For instance, co-processed excipients are gaining traction in the pharmaceutical industry due to their cost-effectiveness and versatility in the drug delivery system.
As new drugs are developed and excipients and co-processed excipients are used more frequently. This is to enhance the bioavailability, dissolution, and disintegration of Active Pharmaceutical Ingredients (API), the growing geriatric and pediatric population is further driving the growth of the market. The sugar-based excipients market is expected to grow due to tight administrative demands that may cause a shortage of FDA-approved products.
In the forecast period, the growth of the sugar-based excipients market is expected to be hampered. This is due to rising administrative demands that may lead to a shortage of FDA-approved manufacturing facilities. Further, the ability of sugar-based excipients to be accepted by administrations may hinder the growth of the sugar-based excipients market. Also, regulatory approval for sugar-based excipients is a major obstacle.
Several opportunities are likely to be created as a result of a shift in concentration from pharmaceutical manufacturing to developing economies. This is likely to further facilitate the growth of sugar-based excipients. The strict quality control processes of prominent manufacturers and the pressure on costs are expected to pose the biggest challenges to the growth of the market.
| Attributes | Details |
|---|---|
| Sugar-based Excipients Size Value in 2023 | US$ 1068.41 million |
| Sugar-based Excipients Forecast Value in 2033 | US$ 1707.46 million |
| Sugar-based Excipients CAGR Global Growth Rate (2023 to 2033) | 4.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
By 2033, the sugar-based excipients are predicted by FMI to reach over US$ 1707.46 million. It is estimated that the global market share increased by 4% in the first half of 2023, which is a market share valued at US$ 1043.66 million. Though not equally distributed throughout all regions, this growth is stronger in developing markets. It is predicted to reach the end of 2023 valued at US$ 1068.41 million with a CAGR of 4.8%.
According to the Connecticut Department of Health's Review published in April 2021, the Pfizer-BioNTech vaccine contains basic table sugar, also known as sucrose, which has positively impacted the market. During freezing, this component helps to maintain a molecule's form. Thus, during the pandemic, the market was significantly impacted.
| Historical CAGR | 4% |
|---|---|
| Historical Market Value (2022) | US$ 1019.48 million |
| Forecast CAGR | 4.8% |
Sugar-Based Excipients Market:
| Attributes | Sugar-Based Excipients Market |
|---|---|
| CAGR (2023 to 2033) | 4.8% |
| Market Value (2023) | US$ 1068.41 million |
| Market Value (2033) | US$ 1645.45 million |
| Growth Factor | Growing popularity in pharmaceuticals and nutraceuticals due to their beneficial properties |
| Opportunity | Increasingly being used to improve the bioavailability of the drug molecule |
| Key Trends | Growing demand for low-dose products and growing requirements for drug delivery systems |
Pharmaceuticals Excipients Market:
| Attributes | Pharmaceuticals Excipients Market |
|---|---|
| CAGR (2023 to 2033) | 6.2% |
| Market Value (2023) | US$ 8910 million |
| Market Value (2033) | US$ 16261 million |
| Growth Factor | Advancements in functional excipients |
| Opportunity | Government investments are increasing in healthcare centers |
| Key Trends | Increasing adoption of binders. |
Nutraceutical Excipients Market:
| Attributes | Nutraceutical Excipients Market |
|---|---|
| CAGR (2023 to 2033) | 7.1% |
| Market Value (2023) | US$ 2507.66 million |
| Market Value (2033) | US$ 4979.25 million |
| Growth Factor | Increasing application in prebiotics and probiotics |
| Opportunity | Advancements in nanotechnology and drug delivery system addressing concerns related to drug toxicity |
| Key Trends | Adoption of nutritional food & dietary supplements |
Principal Consultant
Global access to generic drugs has become a major driver of market growth. A growing market has also been driven by the demand for supplementary excipients due to drug delivery and stability advantages. Moreover, the market is strengthening as the popularity of orally disintegrating tablets increases.
Excipients are essential ingredients to improve general pharmaceutical activity and performance. They directly affect the properties of pharmaceutical formulations. As the elderly population and pediatric patients increase, orally disintegrating tablets will become more popular.
Sugar-based excipients are expected to grow significantly since most of the medications that are used in oral medication are taken by special patients like children, who tend to take fewer medications. Children and other patients are easy to see and attractive depending on the form and testing of the drug. Sugar-based excipients can be easily used and coated with tablets, making them appropriate for most pharmaceutical industries.
As the popularity and development of orally disintegrating tablets grow, the market is booming. Orally disintegrating tablets differ from traditional tablets by dissolving on the tongue rather than swallowing them whole. As the number of geriatric and pediatric patients increases, so does the demand for orally disintegrating tablets.
The study was published in August 2022, entitled "Orally Dispersible Dosage Forms for Pediatric Use: Current Knowledge and Development of Nanostructure-based Formulations". It states that saccharides and sugar alcohols are known for their high-water solubility and taste-enhancing properties and have long been an imperative component of Oro dispersible formulations.
For this reason, several excipient combinations for Orally Dispersible Dosage Forms (ODx) contain monosaccharides and/or their respective alcohols. Sugars and sugar alcohols, along with other excipients, are used to ensure the tablets' uniformity and structural integrity. Therefore, owing to the above benefits of sugar-based excipients in orally dispersible tablets, it is expected that demand for these excipients will increase.
Even though sugar-based excipients are in high demand, increased regulatory requirements and a lack of FDA-approved manufacturing facilities are expected to inhibit their growth. The main challenges for this industry are strict quality control procedures and the price pressures faced by major players.
In general, sugar-based products do not have a fast dissolution rate, high compatibility, or compressibility. Market growth for sugar-based excipients is expected to be hindered by incompatibility with stringent government regulations regarding drug manufacturing and excipient use. According to the European Medicines Agency, excipients should be justified by their role and justification for inclusion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on product, the global sugar-based excipients market is segmented into actual sugar, sugar alcohols, and artificial sweetener. With the highest share in the market, the actual sugars segment is projected to reach a revised size. The market is expected to expand at a CAGR of 4.4% during the forecast period.
The actual sugar segment is projected to reach a revenue share of US$ 750.5 million by 2033. As a result of its increased use in oral prescription medicines, and pediatric formulations because of its low toxicity and high efficiency. Excipients derived from sugar have gained broad recognition as a component of pharmaceutical tablets.
As direct compression has become the preferred method of tablet manufacture, the demand for compressible sugar-based excipients has increased as they can hide the bitter taste of active agents, making them more palatable. It is the increasing birth rate and the growing pediatric patient pool that contribute most to the segment's growth. Sugars are mainly used in oral formulations due to their non-toxicity and negligible drug reactions.
A study published in March 2022 titled " Five-Year Trends in United States Children's Health and Well-being, 2016-2020" outlined in 2019 that there were 73 million children aged 0-17 in the United States, representing 22% of the population. In this way, the growing pediatric population is expected to boost the demand for sugar-based formulations. Furthermore, the strategic initiatives taken by the market players contribute to the segment's growth.
In terms of type, the sugar-based excipients market can be divided into powders, direct compression sugars, crystals, and syrups. The powder segment is expected to hold the largest share of the market throughout the forecast period.
Due to the use of powdered forms for pediatric formulations to bypass the taste of the product. This is because of the increasing number of pediatric patients. As a result, the market is growing.
For instance, the demand for powder excipients is high in the pharmaceutical industry for the production of pediatric formulations with better taste and texture. Also, the increasing geriatric population is boosting the demand for the powder segment.
North America is the largest region in the market and is projected to offer the largest absolute dollar opportunity with a CAGR of 4.1%.
During the forecast period, the North American sugar-based excipient market is expected to remain dominant. Throughout the projection period, the market expansion will be driven by factors such as the rapidly growing pharmaceutical sector, growing demand for functional excipients, the presence of significant players, and technological advancements.
Market growth is also accelerated by the introduction of technologically advanced or superior excipients. For example, Ingestion EMEA, a provider of starch and sugar syrup in the United States, developed sugar alcohol sweeteners in May 2020. It is marketed as ERYSTA Erythritol and can be used in low-calorie products.
Furthermore, strategic actions taken by market participants such as product launches, mergers, and acquisitions contribute to the market segment's growth. To consolidate its global leadership and underscore its commitment to innovation focused on customers, Roquette Group intensified its pharmaceutical business expansion in the Americas in December 2021.
| Country | Insights |
|---|---|
| United States | The United States has the highest growth rate in the market. Most players in the region focus on the development and innovation of sugar-based excipients. The USA sugar-based excipients market is expected to record a healthy CAGR of 3.5% during the forecast period. For instance, the USA pharmaceutical company, Merck & Co., Inc., recently launched a comprehensive range of sugar-based excipients called 'Merck Millipore Direct Compress'. |
| Germany | There are several major pharmaceutical companies and advanced medical technology companies in Germany. Sugar-based excipients are used to develop better medications, which is expected to drive the growth of the market by 2.8%. For example, the German company Merck KGaA has developed the Xiril Xylitol excipient, which is used to improve the taste and stability of drugs without compromising their safety and efficacy. As investments in factors such as drug development and generic drug production have increased, favorable government policies have led Germany to dominate the market for sugar-based excipients. Moreover, the German government provides funds for research and development for excipient manufacturers, allowing them to create high-quality, competitively priced products. |
| China | China is projected to reach revenues of US$ 258.5 million by 2033. This is expected to deliver the fastest CAGR of 6.7%. The Chinese pharmaceutical industry is likely to be a key driver of the sugar-based excipients market growth in the region, due to the increasing consumption of generic drugs. Chinese healthcare has experienced strong growth, and the pharmaceutical industry has advanced. Low manufacturing costs are one of the advantages of favorable policies such as those of the Chinese government. Growth policies in the medical and pharmaceutical industries are also helped by these policies. Generic drug production increased as a result of increased investment in drug development, and government initiatives in China also contributed to the growth of the market. |
Added an Edge to Sugar-based Excipient Dynamics for Emerging Companies
By introducing enhanced products, leveraging technological advances, and gaining a competitive advantage, emerging players are gaining a strategic edge in the sugar-based excipients market. To remain competitive, these firms invest continuously in research and development activities to meet consumer preferences and the needs of end-user industries.
Companies are also investing in developing new sugar-based excipients that are more stable, provide better taste, and have improved functional properties. Additionally, new products with enhanced solubility, viscosity, and other properties are being developed to meet the demands of various industries. For instance,
There are few barriers to entry into the global market, so domestic players will enter in increasing numbers. This will boost their visibility within the forum and contribute to its expansion.
This is because the global market is increasingly accessible, with technology advancing so rapidly and making international trade easier. This allows domestic companies to expand into new markets, increasing their visibility and contributing to the growth of the global market.
Key players operating the global sugar-based excipients market include:
Key Developments for Sugar-based Excipients Market
Sugar-based excipients market players undertake a variety of key activities, including product launches, expansions, and distribution network expansions, as well as establishing global footprints through subsidiaries and partnerships.
These activities enable the manufacturers to obtain a larger market share, as well as enhance their product portfolios and expand their reach to various regions. Additionally, their partnerships with other companies can help them access new markets and gain access to advanced technologies. Major players also diversify their portfolios, acquire companies, and merge.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Chile, Peru, Germany, UK, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey |
| Key Segments Covered | Product, Type, Functionality, Formulation, Region |
| Key Companies Profiled | Ashland Inc.; Associated British Foods Plc; BASF SE; Colorcon, Inc.; Cargill, Inc.; DFE Pharma; FMC Corporation; MEGGLE AG; Roquette Group; The Lubrizol Corporation. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 1068.41 million in 2023.
Ashland Inc., Associated British Foods Plc, and BASF SE are the leading market players.
The market is estimated to reach US$ 1707.46 million in 2033.
Worldwide access to generic drugs drives sugar-based excipients sales.
Actual sugars are likely to remain preferred through 2033.
1. Executive Summary | Sugar-based Excipients Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Products 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Products, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Products, 2023 to 2033 5.3.1. Actual Sugar 5.3.2. Artificial Sweetener 5.3.3. Sugar Alcohol 5.4. Y-o-Y Growth Trend Analysis By Products, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Products, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033 6.3.1. Powders 6.3.2. Direct Compression Sugars 6.3.3. Crystals 6.3.4. Syrups 6.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Functionality 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Functionality , 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Functionality , 2023 to 2033 7.3.1. Fillers & Diluents 7.3.2. Flavouring Agents 7.3.3. Tonicity Agents 7.4. Y-o-Y Growth Trend Analysis By Functionality , 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Functionality , 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Formulation 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Formulation, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Formulation, 2023 to 2033 8.3.1. Oral Formulations 8.3.2. Parenteral Formulations 8.3.3. Topical Formulations 8.4. Y-o-Y Growth Trend Analysis By Formulation, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By Formulation, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. Middle East & Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. The USA 10.2.1.2. Canada 10.2.2. By Products 10.2.3. By Type 10.2.4. By Functionality 10.2.5. By Formulation 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Products 10.3.3. By Type 10.3.4. By Functionality 10.3.5. By Formulation 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Products 11.2.3. By Type 11.2.4. By Functionality 11.2.5. By Formulation 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Products 11.3.3. By Type 11.3.4. By Functionality 11.3.5. By Formulation 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. United Kingdom (UK) 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Products 12.2.3. By Type 12.2.4. By Functionality 12.2.5. By Formulation 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Products 12.3.3. By Type 12.3.4. By Functionality 12.3.5. By Formulation 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Products 13.2.3. By Type 13.2.4. By Functionality 13.2.5. By Formulation 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Products 13.3.3. By Type 13.3.4. By Functionality 13.3.5. By Formulation 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Products 14.2.3. By Type 14.2.4. By Functionality 14.2.5. By Formulation 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Products 14.3.3. By Type 14.3.4. By Functionality 14.3.5. By Formulation 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Products 15.2.3. By Type 15.2.4. By Functionality 15.2.5. By Formulation 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Products 15.3.3. By Type 15.3.4. By Functionality 15.3.5. By Formulation 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Products 16.2.3. By Type 16.2.4. By Functionality 16.2.5. By Formulation 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Products 16.3.3. By Type 16.3.4. By Functionality 16.3.5. By Formulation 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Products 17.1.2.2. By Type 17.1.2.3. By Functionality 17.1.2.4. By Formulation 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Products 17.2.2.2. By Type 17.2.2.3. By Functionality 17.2.2.4. By Formulation 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Products 17.3.2.2. By Type 17.3.2.3. By Functionality 17.3.2.4. By Formulation 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Products 17.4.2.2. By Type 17.4.2.3. By Functionality 17.4.2.4. By Formulation 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Products 17.5.2.2. By Type 17.5.2.3. By Functionality 17.5.2.4. By Formulation 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Products 17.6.2.2. By Type 17.6.2.3. By Functionality 17.6.2.4. By Formulation 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Products 17.7.2.2. By Type 17.7.2.3. By Functionality 17.7.2.4. By Formulation 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Products 17.8.2.2. By Type 17.8.2.3. By Functionality 17.8.2.4. By Formulation 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Products 17.9.2.2. By Type 17.9.2.3. By Functionality 17.9.2.4. By Formulation 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Products 17.10.2.2. By Type 17.10.2.3. By Functionality 17.10.2.4. By Formulation 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Products 17.11.2.2. By Type 17.11.2.3. By Functionality 17.11.2.4. By Formulation 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Products 17.12.2.2. By Type 17.12.2.3. By Functionality 17.12.2.4. By Formulation 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Products 17.13.2.2. By Type 17.13.2.3. By Functionality 17.13.2.4. By Formulation 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Products 17.14.2.2. By Type 17.14.2.3. By Functionality 17.14.2.4. By Formulation 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Products 17.15.2.2. By Type 17.15.2.3. By Functionality 17.15.2.4. By Formulation 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Products 17.16.2.2. By Type 17.16.2.3. By Functionality 17.16.2.4. By Formulation 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Products 17.17.2.2. By Type 17.17.2.3. By Functionality 17.17.2.4. By Formulation 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Products 17.18.2.2. By Type 17.18.2.3. By Functionality 17.18.2.4. By Formulation 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Products 17.19.2.2. By Type 17.19.2.3. By Functionality 17.19.2.4. By Formulation 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Products 17.20.2.2. By Type 17.20.2.3. By Functionality 17.20.2.4. By Formulation 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Products 17.21.2.2. By Type 17.21.2.3. By Functionality 17.21.2.4. By Formulation 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Products 18.3.3. By Type 18.3.4. By Functionality 18.3.5. By Formulation 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. British Foods Plc 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Ashland Inc. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. DFE Pharma 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Colorcon, Inc. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. FMC Corporation 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Meggle AG 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. The Lubrizol Corporation 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Roquette Group 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Archer Daniels Midland Company 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. BASF SE 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Food and Beverage Insights
View Reports
Sugar-based Excipients Market
